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Abstract
Background: Lead has significant neuro-toxic effects, particularly for young children. Voluntary screening of pre-school
aged children for elevated blood lead levels has been an important part of the lead management program in the
mining town of Broken Hill (NSW, Australia) since 1991, where lead remains a significant public health issue for young
children despite average blood lead levels having fallen by two-thirds. The annual proportion of children screened
declined to 0.39 in 2008. The objective of this study was to determine the impact of changing to capillary screening
and linking screening with existing routine health programs on participation in blood lead screening by young
children in the community.
Methods: We used a before-after study. Screening rates were determined from routinely collected service data and
analysed using cross-sectional and cohort analyses.
Results: The proportion of children screened annually increased from 0.39 in 2008 to 0.75 in 2012, with the greatest
increases among 11–23 and 48–59 month old children. The proportion of children screened at least once by
24 months increased from 0.63 for children born in 2007 to 0.98 for children born in 2010. Attendance stabilized
after capillary screening was introduced, and increased markedly after screening was offered at immunization.
Conclusons: Changing from venous to capillary screening stabilized attendance and improving convenience was
associated with dramatically increased screening. Linking screening with well-accepted mainstream child health
programs is an effective strategy to improve participation in blood lead screening programs. The findings have
implications for improving participation in other health screening programs.
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Background
Lead has significant neuro-toxic effects, particularly for
young children [1, 2]. Emerging evidence about the ef-
fects of chronic low blood lead levels highlights the im-
portance of a systemic approach to reducing community
lead exposure [3–8]. In response there is increasing
emphasis on primary prevention and several countries
have reduced their blood lead thresholds for investiga-
tion of an individual’s source of exposure from 10 to
5 μg/dL or lower [3, 9–12].
Screening at-risk populations is an important compo-
nent of lead control programs, both detecting individuals
who may benefit from available advice and interventions,
and monitoring the effectiveness of community-wide ef-
forts to reduce blood lead levels [9, 13, 14]. To succeed
screening programs must be both acceptable and access-
ible to the community. As with other health issues for
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which screening is appropriate, blood lead screening is
more acceptable when it is less invasive, easily accessible,
and when people believe something can be done about
the health issue if a problem is detected [15]. Participa-
tion in blood lead screening programs varies widely, and
may be very difficult to increase [15–18].
Voluntary screening of pre-school aged children for el-
evated blood lead levels has been an important part of
the lead management program in Broken Hill (NSW,
Australia) since 1991, when lead was identified as an im-
portant community public health issue [19]. The average
blood lead level of 1–4 year old children has fallen by
67 % since 1991. However, lead is still an important pub-
lic health issue for the local community, with 21 % of
children screened in 2012 having blood lead levels of
10 μg/dLor higher [1, 20].
During the 1990s the proportion of eligible children
screened each year varied markedly: 0.50–0.65 were
screened most years; screening peaked at 0.72 in 1994
and 0.73 in 1998 in response to more intensive program
activity and reached a low of 0.39 in 1993 when program ac-
tivity was minimal due to restricted funding [19]. The lead
management program initially operated as a separate entity,
but in 2001 it was integrated with mainstream services to
ensure its sustainability; subsequently funding decreased sig-
nificantly. Attendance at screening declined steadily, from
0.56 in 2001 to 0.39 for all 1–4 year old children in 2008;
and to 0.25 for Indigenous children in 2009 [19–21]. Com-
munity consultations identified several possible barriers to
attending screening including parental perceptions that the
collection of the blood sample caused discomfort to children
and access to the weekly screening clinic was inconvenient,
and highlighted the importance of screening occurring
within a culturally acceptable model [22, 23].
The aim of this study is to evaluate the effectiveness of
changes to the blood lead screening protocol to examine:
1. the impact of the changes on cumulative and overall
blood lead screening rates and service provision, and
the relative importance of changing the screening
method and improving access;
2. whether all children have benefited from the changes
and if further outreach is required for any particular
group;
3. the effect of changing to capillary screening on the
estimate of the underlying mean blood lead level.
Method
Study design
A before-after study based on routinely collected data.
The intervention
Capillary screening using the LeadCare II was introduced
in October 2008 and subsequently linked with existing
well-accepted programs to improve accessibility and
convenience for parents as described below. From 2010
screening was incorporated into routine healthy children
checks at the local Indigenous health service (rather than
being available once or twice a year). From 2011 screening
was offered when children attended the mainstream com-
munity health service for immunization (offered at 18 month
immunization from March and for all immunizations—
12 months, 18 months and 4 years—from September).
Text message (SMS) appointment reminders were also
introduced by the mainstream health service in May
2011. Confirmatory venous tests are offered for blood
leads ≥15 μg/dL.
The LeadCare II is a point of care testing device for
analyzing whole blood lead samples; it received a Clinical
Laboratory Improvement Ammendment of 1988 (CLIA)
waiver in 2006. It was the only commercially available
point of care testing euipment for measuring blood lead
levels. FDA has approved this technology for blood lead
testing in non-traditional laboratory settings as long as
appropriate training and finger cleaning procedures are
instituted [24].
Data sources
Numerator data for all analyses were obtained from rou-
tinely collected data extracted from the Lead Management
Program ACCESS database, which contains information
on all blood lead tests conducted at both the mainstream
and Indigenous health clinics. Data were extracted for all
7–59 month old children who had a blood lead test be-
tween 1/1/2005 and 31/12/2012 (approximately 10,100 re-
cords) and were resident in Broken Hill at the time. The
items extracted were: birth date, sex, date of test, address,
area of town and numeric identifier (assigned at first blood
lead test). Address was used to code for one of five lead
risk zones within Broken Hill and then removed from the
dataset to protect confidentiality. Thirteen records (six
children) were excluded from further analysis because the
child’s residential address could not be confirmed (for
example, was listed as a post office box) and 11 records
(five children) because sex was not documented. This
left data on 2287 children for analysis.
The number of children usually resident in each locality
was used as the denominator for calculating annual at-
tendance rates and was estimated using 2006 and 2011
Australian Bureau of Statistics (ABS) census data [25, 26].
Change between the two censuses was assumed to be
linear. The number of children born to mothers resident
in Broken Hill was used as the denominator for cohort
attendance rates and was estimated from the NSW
Midwives Database (NMD) (Centre for Epidemiology
and Research, NSW Ministry of Health). Analysis was
conducted using Microsoft Excel 2010 and SAS 9.4.
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Analysis
To assess the impact of changes to the screening proto-
col on cumulative attendance rates, we calculated the
proportion of children screened at least once by 12, 18,
24, 48 and 59 months for each annual birth cohort be-
tween 2005 and 2011.
To examine the effect of the changes on service
provision, all available screening data was used to calculate
the number of days screening was available each calendar
year and the average number of children screened each day.
We examined the change in overall attendance after the
new screening method was introduced and after screening
was linked with immunization and SMS reminders intro-
duced. To facilitate comparison with previous publications
[19, 27] this analysis was restricted to 12–59 month old
children. If a child was screened more than once in a cal-
endar year, only the first test was included to avoid double
counting. Piecewise linear regression was used to allow
(and test for) change in slope at chosen cut-points to
compare the trend in the proportion of children screened
during three periods: 2005–2008 when venous screening
was available; 2008–2010 when capillary screening was
available and 2010–2012 when screening was linked with
immunization and text reminders introduced. The signifi-
cance of the change in proportion of children screened at
the beginning and end of each period was assessed by cal-
culating the difference in proportions and associated 95 %
confidence intervals.
To assess whether all children in the community have
benefited from the changes to the screening protocol
and if further outreach is required for any particular
group, we estimated the proportion of 12–59 month old
children screened in a given year and used stratified ana-
lysis to examine the impact of age, gender, locality and
year of testing on attendance rates. Difference in propor-
tions and associated confidence intervals were used to
compare attendance at particular time points. For these
analyses, tests occurring before a child’s first birthday
were excluded, and if a 12–59 month old child had more
than one test in a calendar year only the first test was
used. The two areas with the highest environmental lead
risk (zones 1 and 2) had small numbers of children, and
were combined for all analyses to improve the robustness
of estimates.
Because capillary screening returns slighlty higher values
than venous, we calculated geometric mean and 95 %
confidence intervals for 12–59 month old children for
2005–2012 to determine whether there was a consistent
difference in mean after the change to capillary testing.
Geometric means were used because the blood lead values
were not normally distributed without the logarithimic
transformation. As a further check we also calculated the
annual proportion of children with test results equal to or
greater than 5 and 10 μg/dL.
Ethical approval
The study was approved by the Greater Western Area
Health Service Human Research Ethics Committee (Refer-
ence No. HREC/11/GWAHS/7) and the approval was ac-
cepted by the Executive Committee of the University of
Sydney Human Research Ethics Committee (Reference
No. 13716).
Results
Attendance by birth cohort
The change to capillary screening was associated with a
marked increase in screening among children who were
less than 12 months old when the change was introduced
(Fig. 1). The proportion of children screened by 12 months
was 0.39 for children born in 2007 compared with 0.60 for
children born in 2008 (0.21 increase; 95 % confidence in-
tervals increase of 0.12–0.29). However, screening rates of
children who were older when capillary screening was in-
troduced did not increase. For example, children born in
2007, who were 10–22 months when capillary screening
was introduced in October 2008, had slightly lower cumu-
lative screening rates by 24 months than children born in
2006 (0.63 and 0.69 respectively, 0.06 reduction in screen-
ing, 95 % confidence intervals increase of 0.14 reduction
to 0.03 increase). Estimated cumulative attendance for
screening was slightly above 100 % for children born in
2008, 2009 and 2010 (106, 105 and 105 % respectively).
Offering screening when children attended for
immunization markedly increased screening rates. The
proportion of children screened at least once by 24 months
increased from 0.63 for children born in 2007 to 0.98 for
children born in 2010 (0.34 increase in screening, 95 %
confidence intervals increase of 0.28–0.41).
Service availability
The number of days when screening was available more
than doubled after screening was offered to children at-
tending for immunization, from 80 screening days in
2010 to 184 screening days in 2012 (Table 1). Although
the average number of children screened per screening
day decreased by a quarter during the same period, the
number of children screened per year increased by 70 %.
Overall screening participation
Overall participation of 12–59 month old children in
screening showed three distinct phases (Fig. 2). From 2005
to 2008 the proportion of children screened annually de-
creased from 0.59 in 2005 to 0.39 in 2008 (decrease = 0.29;
95 % CI decrease of 0.16–0.25) and regression analysis esti-
mated attendance was falling steadily at about 6 % per year:
y = 0.58207–0.06197, P =0.0068; where the intercept
(0.58207) gives the predicted proportion screened in 2005
and the coefficient for year (−0.06197) gives the ex-
pected change per year from 2005 to 2008. After capillary
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screening was introduced the proportion of children
screened increased slightly from 0.39 in 2008 to 0.44 in
2010 (increase of 0.05; 95 % CI increase of 0.00–0.09) and
regression analysis confirmed the underlying trend had
changed direction, with attendance predicted to increase
by about 9 % per year from 2008 to 2010: y = 0.58207–
0.06197 + 0.08782; P =0.0288. Attendance increased mark-
edly when screening was linked with immunization and
SMS reminders were introduced, rising to 0.75 in 2012
(increase of 0.31, 95 % CI increase of 0.27–0.35) and re-
gression analysis confirmed a significant change in under-
lying trend, with attendance predicted to increase by 13 %
per year for 2010–2012: y = 0.58207–0.06197 + 0.08782 +
0.13048; P =0.0158.
Locality, age and gender specific attendance rates
At the beginning of the study period children living in
the highest lead risk zones were more likely to attend
than children living in other areas (0.90 vs 0.51 %–0.57;
difference = 0.33, 95 % CI difference of 0.26–0.40) but
their attendance declined more rapidly and by 2010 was
similar to that of children living in other areas (0. 48 vs
0.33–0.46). Attendance increased for children living in
all areas of town after screening was linked with
immunization, but increased more slowly for children
living in the highest lead risk districts; so that by 2012
their attendance was midrange (0.71 vs 0.64–0.80).
One-year-old (i.e., 12–23 months) children consistently
had the highest annual attendance rates across the study
period. Prior to the introduction of capillary screening this
ranged from 0.75 in 2005 to 0.53 on 2008. Attendance
increased markedly after screening was offered with the
18-month immunization in 2011. By 2012, 1.00 (238,
from an estimated population of 233) of 1-year-olds were
screened. Four-year old children consistently had lower
screening rates than younger children (0.24–0.43 vs 0.37–
0.59 for 3-year olds and 0.43–0.66 for 2-year-olds) until
screening was offered with the 4-year-old immunization
in 2011, after which their attendance increased markedly
and slightly exceeded that of 2 and 3 year olds (0.73 vs
0.61–0.62).
In most years screening rates were 0.08–0.10 higher for
boys than girls; both showed similar changes in attend-
ance over time.
Table 1 Estimated birth cohorts, attendance at blood lead screening by 12–59 month old children in Broken Hill, 2005–2012:
number screened, number of days on which screening was provided, and average number of children screened per day
2005 2006 2007 2008a 2009 2010b 2011c 2012
Estimated birth cohort (NMD) 237 218 240 236 216 228 190 -
Children screened 563 456 456 361 376 397 554 665
Number of screening days 53 46 53 72 76 80 148 184
Average number children screened per screening day 10.34 9.76 8.66 5.01 4.75 5 4 3.66
aCapillary introduced October 2008
bScreening regularly available at local indigenous health clinic
cScreening offered at 18 month immunization in March and at all immunizations from September; SMS appointment reminders introduced in May
Fig. 1 Estimated cumulative proportion of Broken Hill children having their blood lead levels screened at least once for specific annual birth cohorts
(2005, 2007, 2009 and 2011)
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Effect of changing to capillary method on estimate of
population blood lead levels
There was no evidence that changing to capillary sam-
pling affected the estimate of the underlying population
blood lead level (Table 2). The mean blood lead level did
not increase after capillary screening was introduced,
but continued to fluctuate at or slightly below levels ob-
served during the first 3 years of the study period (when
only venous sampling occurred). Similarly there was no
consistent change in the proportion of children screened
who had blood lead levels equal to or above 5 or 10 μg/dL
(Table 2).
Discussion
The changes to the screening protocol were associated
with a significant increase in overall annual screening par-
ticipation, from 0.39 in 2008 to 0.75 in 2012. This exceeded
the program’s previous highest participation rates (72 and
73 %), achieved in 1994 through a community-wide door-
knock and in 1998 through heightened program activity
[19]. Importantly, attendance has increased for children in
all age groups, living in all areas of town and for both boys
and girls. The increased attendance has been maintained,
reaching 0.78 in 2013 [27]. By 2012 the program met local
targets for screening and recommendations for universal
screening in areas with high blood lead levels [14, 28].
Current screening rates are now among the highest re-
ported for any established lead screening programs [15].
Before these changes were made, the proportion of eli-
gible children screened each year had declined steadily
for a decade [20, 21]. Other long-running lead manage-
ment and screening programs have reported declines in
attendance over time which can be difficult to reverse
[29–32]. Nevertheless, dissemination of screening guide-
lines, highlighting lead risks to local physicians and fo-
cussing on children at high risk of lead exposure have
increased blood lead screening rates in some communities
[33, 34]; the increase achieved in Broken Hill exceeds
these.
It is notable that the increased screening participation
occurred without additional funding. Many voluntary blood
lead screening programs with high participation rates are
associated with substantial home remediation programs if
children are found to have high blood lead levels [32, 35] or
significant outreach programs [36]. The Broken Hill
program has not had the funding for either of these
since 2001 and has achieved the increased participation
within existing resources. While this makes it sustainable
Fig. 2 Estimated proportion* of 12–59 month old children screened for lead in Broken Hill before and after the introduction of screening by
capilliary in October 2008 and offering screening with immunisation from 2011
Table 2 Annual blood lead screening metrics, Broken Hill 2005–2012; 12–59 month old children
2005 2006 2007 2008 2009 2010 2011 2012
Children screened 563 456 456 361 376 397 553 665
0.60 0.48 0.49 0.39 0.41 0.44 0.62 0.75
Geometric mean (μg/dL) 5.7 6.1 5.9 4.8 5.8 4.7 4.8 5.4
Lower 95 % CI (μg/dL) 5.4 5.7 5.5 4.5 5.5 4.4 4.6 5.2
Upper 95 % CI (μg/dL) 6.1 6.5 6.3 5.2 6.2 5.0 5.0 5.7
Proportion children with blood leads equal to or greater than 5 μg/dL 0.64 0.69 0.66 0.52 0.61 0.40 0.45 0.52
Proportion children with blood leads equal to or greater than 10 μg/dL 0.37 0.40 0.40 0.32 0.34 0.33 0.27 0.39
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from an organisational point of view, there is public frus-
tration about the lack of community-wide action or sup-
port to help families whose children have high blood lead
levels but who are unable to implement some lead risk re-
duction activities (e.g., putting down clean soil) because of
financial constraints [22]. A recent announcement by the
NSW government to invest in a further lead abatement
program for Broken Hill has been well received by the
community [37].
The effect of the availability of capillary screening
varied with age. Attendance of children who were
12 months or younger increased significantly when ca-
pillary screening was introduced but there was no change
for older children. This differential uptake by different age
groups is the reason that overall attendance only increased
slightly after capillary screening was introduced.
The largest increase in participation occurred after
screening was linked with immunization, which is congru-
ent with previous findings that convenience and cultural
appropriateness are critical for optimizing screening rates
[34, 38, 39]. However we consider it unlikely that par-
ticipation would have increased as much as it did if the
screening method had not been changed to capillary.
Acceptibility to the target population is an important
component of screening, and parents are less willing to
have children screened if they perceive that the testing
method is painful [22, 38]. Moreover, community con-
sultations in Broken Hill had previously identified ven-
ous blood collection as contributing to reluctance to
have children screened [22]. We conclude that both ca-
pillary screening and more convenient access were im-
portant for increasing screening participation in Broken
Hill.
Increased screening participation does not necessarily
indicate increased community awareness of lead as a
health issue, or better health outcomes. Nevertheless, while
increased screening participation will not in itself reduce
community lead risk, it is still an important achievement.
Screening provides a point of interaction between health
professionals and the community, and importantly the re-
sults of screening have confirmed lead is still an important
public health issue in Broken Hill and provided the basis
for advocacy for increased funding to reduce community
lead exposure.
It is unclear how the change to capillary screening af-
fected the estimate of the population blood lead level
and proportion of children with blood lead levels ≥5 μg/dL
and ≥10 μg/dL. We would have expected a one-off increase
in estimates of the mean blood lead level and proportions
of children with blood lead ≥5 μg/dL and 10 μg/dL (refs)
[40], but this did not happen. Instead these estimates
fluctuated at or slightly below the previously observed
range. It may be that the increase in estimates that
would have been expected from the change in method
has been compensated for by accessing a much greater
proportion of the population. From a primary prevention
perspective, it is important that the capillary method has
not given false negatives. The suitability of the current
equipment will need to be reviewed in light of the recent
reduction of the Australian threshold for investigation of
an individual’s lead exposure to 5 μg/dL [41].
The study has two limitations. The first arises from
using administrative data sets to calculate denominators.
Denominators for the cross-sectional analyses were esti-
mated from the 2005 and 2011 Australian Censuses. We
assumed that change between census years was linear
but that may not have been the case. Similarly, there is
some uncertainlty with the data on the NSW Midwives
Data Collection, which was used to estimate denomina-
tors for the cohort analysis, due to a time delay in enter-
ing data for children born out of state, and the fact it
does not account for in/out migrationafter birth. These
factors would account for cumulative cohort attendance
rates exceeding 100 % in some years.
The use of a before and after study limited our ability
to examine for other factors that might have influenced
screening rates, and to consider the possibility that offer-
ing venous screening at routine visits may have similarly
increased attendance. However, attendance rates had
been declining steadily since 2001 and the decline stopped
the same year capillary screening was introduced. Attend-
ance increased by 5 % over the next 2 years, mainly among
infants presenting for their first test (prior to providing
screening alongside other well-accepted mainstream
programs). Previous evidence [22] suggested the use of
venipuncture had resulted in parental reluctance to at-
tend thus we consider the change in screening method
was most likely explanation for increased participation
in this age group. During the 1990s screening rates peaked
during times of increased program activity, but there was
no increased program activity during the study period.
Similarly because the study was undertaken in one com-
munity and there is no control community we can’t rule
out broader factors (such as national health promotion
campaigns) which could have increased screening, al-
though we are unaware of any such campaigns having
occurred during the study period.
Conclusions
Making changes to a long standing blood lead screening
protocol successfully increased participation. Using a
screening method acceptable to the community and pro-
viding screening alongside other well-accepted mainstream
programs for children has the potential to improve partici-
pation in other blood lead screening programs. These find-
ings also have implications for improving participation in
other health screening programs. Further research is re-
quired to assess the effectiveness of this approach in other
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communities, whether the improved attendance is main-
tained in the medium to long term, and whether par-
ticipation rates can be increased to acceptable levels by
increasing the convenience of access alone.
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